Open AccessS300: HEALTH‐RELATED QUALITY OF LIFE IN TRANSPLANT‐INELIGIBLE REAL‐LIFE MULTIPLE MYELOMA PATIENTS TREATED WITH BORTEZOMIB‐MELPHALAN‐PREDNISONE (VMP) VS. LENALIDOMIDE‐DEXAMETHASONE (RD)
Author(s) -
D'Agostino M.,
Bringhen S.,
Ria R.,
Ciceri F.,
Falcone A. P.,
Michieli M.,
Grasso M.,
Pane F.,
Quaresima M.,
Cattel F.,
Mirabile M.,
Fioritoni F.,
Petrucci M. T.,
Cotugno V.,
Capra A.,
Pezzatti S.,
Mosca Siez M. L.,
Cantonetti M.,
Margiotta Casaluci G.,
Bertazzoni P.,
Floris R.,
Offidani M.,
Pietrantuono G.,
Evangelista A.,
Boccadoro M.,
Larocca A.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000844092.71570.04
Subject(s) - medicine , lenalidomide , multiple myeloma , population , quality of life (healthcare) , context (archaeology) , randomized controlled trial , interim analysis , prednisone , physical therapy , surgery , paleontology , nursing , environmental health , biology